Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06144385
Status:
RECRUITING
Last Update Posted:
2024-01-02
First Post:
2023-11-15
Brief Title:
A Phase 1 Single-arm Open-label Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Sponsor:
Shanghai Ming Ju Biotechnology Co Ltd
Organization:
Shanghai Ming Ju Biotechnology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-15
First Submit QC Date:
November 20 2023
Study First Post Date:
2023-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-27
Last Update Post Date:
2024-01-02
Last Update Post Date Type:
ACTUAL